Many people are doing an end-run around their doctor's office, reaching out to potentially unreliable sources that promise to ...

Nestlé's newest product line "Vital Pursuit" is a slate of low-calorie, high-protein meals that are designed to be relatively ...

Wegovy, Zepbound and other cutting-edge weight-loss drugs can be tough to get these days.They’re in short supply, ...

Adults over 18 years of age are needed to participate in nutrition study to learn more about the effects of protein on body ...

Meanwhile, Lilly’s 2023 revenue exceeded $34 billion, growing 20% year-over-year. Its tirzepatide brands Mounjaro and ...

The demand for medications like Ozempic continues to cause shortages for both those seeking weight loss and patients with ...

Noom is the latest digital health company to jump into the off-label weight loss drug market to make medications more ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 597.82% and ...

In an unconventional alliance, North Carolina State Treasurer Dale Folwell, a Republican, spoke on Capitol Hill at a ...

Rhythm Pharmaceuticals (RYTM) stock gains as JMP Securities issues a positive view on the company citing its lead product ...

The move to self-administration with a syringe and needle, just like how insulin is often taken for diabetes, means a whole ...

Consistent in their evaluation, an analyst from JP Morgan keeps a Overweight rating on Eli Lilly with a target price of $1100 ...